Skip to content

A Clinical Study on the Effect of Sri Siddha Modaka in the Management of (Pabdu roga)Anaemia.

A SINGLE ARM CLINICAL STUDY ON THE EFFICACY OF SRI SIDDHA MODAKA IN PANDU ROGA(ANAEMIA) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103799
Enrollment
30
Registered
2026-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D539- Nutritional anemia, unspecified Health Condition 2: D649- Anemia, unspecified

Interventions

None listed

Sponsors

Dr.Rishitha K A
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participants above the age of 18 years and below 60 years irrespective of caste, gender, religion and socio-economic status. 2.Participants with Hemoglobin Percentage less than 10 gm per dL for both Male and Female. 3.Participants with altered RBC indices, MCV (Mean Corpuscular Volume) less than 80fL or more than 100fL MCHC (Mean Corpuscular Hemoglobin Concentration) less than 32 g per dL PCV (Packed Cell Volume) less than 36% in females, more than 41% in males 4.Participants with abnormal RBC morphology on peripheral smear (e.g., microcytosis, hypochromia, anisocytosis, poikilocytosis) 5.Participants who have received any iron or hematinic supplementation in past 30 days will be enrolled out only after ensuring a washout period of at least 4 weeks prior to initiating the intervention to minimize carryover effects. 6.Participants willingness to give written informed consent and ability to comply with scheduled visits, treatment plans and laboratory tests and other study procedure.

Exclusion criteria

Exclusion criteria: 1.Participants with diagnosed cases of Anemia due to chronic systemic illnesses (e.g. malignancies, tuberculosis, CKD stages 3b-5(End Stage renal disease)). 2.Participants with Uncontrolled Systemic disorders (E.g.: Hypertension, diabetes mellitus, Thyroid disorder) 3.Pregnant and lactating women. 4.Severe anemia requiring immediate blood transfusion (Hb percentage less than 6 gm per dL). 5.Participants diagnosed with Haemoglobinopathies such as Sickle cell anaemia, Leukaemia, Haemolytic anaemia and Thalassaemia. 6.Participants diagnosed with active bleeding disorders such as Haemorrhoids, menorrhagia, gastro intestinal bleeding. 7.Participants diagnosed with anaemia due to malabsorption syndromes (e.g. post-gastrectomy, sprue syndrome, etc.) 8.Participants who are known case of HIV, leprosy and other immune compromised conditions. 9.Participants with diagnosed cases of infectious diseases (e.g. dengue, malaria etc.).

Design outcomes

Primary

MeasureTime frame
A Measurable Changes in Classical Signs and Symptoms and Red Blood Cell Morphology In Individuals Diagnosed With Pandu Roga(Anaemia).Timepoint: 30 days

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDrPrashanth Bhat

A.L.N Rao Memorial Ayurvedic Medical College

drprashanthbhat@outlook.com9449156930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026